Literature DB >> 23073951

Trends in lipids and lipoproteins in US adults, 1988-2010.

Margaret D Carroll1, Brian K Kit, David A Lacher, Susan T Shero, Michael E Mussolino.   

Abstract

CONTEXT: Serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) contribute to atherosclerosis and its clinical consequences. Between the periods 1988-1994 and 1999-2002, mean TC and mean LDL-C declined in adults. During this time, there was an increase in the percentage of adults receiving lipid-lowering medications. Geometric mean triglyceride levels increased but mean high-density lipoprotein cholesterol (HDL-C) remained unchanged. OBJECTIVE To examine trends in serum lipids in adults between 1988 and 2010. DESIGN, SETTING, AND PARTICIPANTS Three distinct US cross-sectional National Health and Nutrition Examination Surveys, 1988-1994 (n = 16,573), 1999-2002 (n = 9471), and 2007-2010 (n = 11,766). MAIN OUTCOME MEASURES: Mean TC, LDL-C, HDL-C, non-HDL-C, and geometric mean triglyceride levels and the prevalence of lipid-lowering medication use.
RESULTS: Mean TC declined from 206 (95% CI, 205-207) mg/dL in 1988-1994 to 196 (95% CI, 195-198) mg/dL in 2007-2010 (P <.001 for linear trend); mean LDL-C declined from 129 (95% CI, 127-130) mg/dL to 116 (95% CI, 114-117) mg/dL (P <.001 for linear trend). Mean non-HDL-C declined from 155 (95% CI, 153-157) mg/dL in 1988-1994 to 144 (95% CI, 143-145) mg/dL in 2007-2010 (P <.001 for linear trend). Mean HDL-C increased from 50.7 (95% CI, 50.0-51.0) mg/dL during 1988-1994 to 52.5 (95% CI, 51.8-53.2) mg/dL in 2007-2010 (P =.001 for linear trend). Geometric mean serum triglyceride levels increased from 118 (95% CI, 114-121) mg/dL in 1988-1994 to 123 (95% CI, 119-127) mg/dL in 1999-2002 and decreased to 110 (95% CI, 107-113) mg/dL in 2007-2010 (P <.001 for quadratic trend). The prevalence of lipid-lowering medication use increased from 3.4% (95% CI, 2.9%-3.9%) in 1988-1994 to 15.5% (95% CI, 14.7%-16.3%) in 2007-2010 (P <.001 for linear trend). Among adults not receiving lipid-lowering medications, trends in lipids were similar to those reported for adults overall. Among obese adults, mean TC, non-HDL-C, LDL-C, and geometric mean triglycerides declined between 1988 and 2010.
CONCLUSION: Between 1988 and 2010, favorable trends in lipid levels have occurred among adults in the United States.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23073951     DOI: 10.1001/jama.2012.13260

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  101 in total

1.  Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.

Authors:  Brent M Egan; Jiexiang Li; Suparna Qanungo; Tamara E Wolfman
Journal:  Circulation       Date:  2013-07-02       Impact factor: 29.690

Review 2.  Bringing genome-wide association findings into clinical use.

Authors:  Teri A Manolio
Journal:  Nat Rev Genet       Date:  2013-07-09       Impact factor: 53.242

3.  Temporal trends in clinical characteristics of patients without known cardiovascular disease with a first episode of myocardial infarction.

Authors:  Binita Shah; Sripal Bangalore; Eugenia Gianos; Li Liang; W Frank Peacock; Gregg C Fonarow; Warren K Laskey; Adrian F Hernandez; Deepak L Bhatt
Journal:  Am Heart J       Date:  2014-01-04       Impact factor: 4.749

4.  A snapshot of lipid levels in the Republic of Ireland in 2017.

Authors:  Ruth Agar; Catherine Markham; Meabh Prendergast; Rebecca Canning; Edana Maher; Caroline Finn; Nuala Sammon; Sarah Fall; Noeleen Fallon; Evonne Hanrahan; Lisa King; Vincent Maher
Journal:  Ir J Med Sci       Date:  2018-06-01       Impact factor: 1.568

Review 5.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

6.  The Revised Nutrition Facts Label: A Step Forward and More Room for Improvement.

Authors:  Vasanti S Malik; Walter C Willett; Frank B Hu
Journal:  JAMA       Date:  2016-08-09       Impact factor: 56.272

Review 7.  Genetic and environmental determinants of the susceptibility of Amerindian derived populations for having hypertriglyceridemia.

Authors:  Carlos A Aguilar-Salinas; Teresa Tusie-Luna; Päivi Pajukanta
Journal:  Metabolism       Date:  2014-03-30       Impact factor: 8.694

8.  Understanding nutritional epidemiology and its role in policy.

Authors:  Ambika Satija; Edward Yu; Walter C Willett; Frank B Hu
Journal:  Adv Nutr       Date:  2015-01-15       Impact factor: 8.701

Review 9.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

10.  Hemoglobin A1c Level and Cardiovascular Disease Incidence in Persons With Type 1 Diabetes: An Application of Joint Modeling of Longitudinal and Time-to-Event Data in the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  Rachel G Miller; Stewart J Anderson; Tina Costacou; Akira Sekikawa; Trevor J Orchard
Journal:  Am J Epidemiol       Date:  2018-07-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.